Michael Swinford

CIK: 0002020514

Transaction Breakdown

Open Market Buys (P)3 (75.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LFWD

Lifeward Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

LFWD
Lifeward Ltd.
Aug 1, 2025
Award(A)
Indirect
35.9K shares-
LFWD
Lifeward Ltd.
Nov 25, 2024
Purchase(P)
Direct
21.6K shares at avg. $2.03$44K
LFWD
Lifeward Ltd.
Nov 22, 2024
Purchase(P)
Direct
16.9K shares at avg. $1.83$31K
LFWD
Lifeward Ltd.
Nov 20, 2024
Purchase(P)
Direct
16.5K shares at avg. $1.84$30K

		Type	Shares	Price		Ownership
Aug 1, 2025	LFWD Lifeward Ltd.	Award(A)	35,920	-	-	Indirect
Nov 25, 2024	LFWD Lifeward Ltd.	Purchase(P)	21,622	$2.03	$43,858	Direct
Nov 22, 2024	LFWD Lifeward Ltd.	Purchase(P)	16,907	$1.83	$30,899	Direct
Nov 20, 2024	LFWD Lifeward Ltd.	Purchase(P)	16,471	$1.84	$30,231	Direct

1-4 of 4 transactions

About Swinford Michael

Swinford Michael (SEC CIK 0002020514) files insider reports with the SEC as Director of Lifeward Ltd. (LFWD).

Signal8 holds 4 ownership filings by Swinford Michael, all Form 4s, filed between Nov 25, 2024 and Aug 7, 2025. Those filings report 4 transactions, from Nov 20, 2024 to Aug 1, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Swinford Michael's filings is in MARLBOROUGH, MA.

Recent filings by Swinford Michael

Aug 1, 2025: Grant or award of LFWD shares (Form 4, code A).
Nov 25, 2024: Open-market purchase of LFWD shares (Form 4, code P).
Nov 22, 2024: Open-market purchase of LFWD shares (Form 4, code P).
Nov 20, 2024: Open-market purchase of LFWD shares (Form 4, code P).

Other insiders filing for Lifeward Ltd. (LFWD)

Zamir Haggai, Director
Hexter Joshua, Officer
Greenwald Yonason, Director
Gabay Avraham, Director
Rose Keith Dale, Chief Medical Officer
ORAMED PHARMACEUTICALS INC., 10% Owner

How to read Form 4 transaction codes